![](/img/cover-not-exists.png)
Switching to the single-tablet regimen of elvitegravir, cobicistat, emtricitabine, and tenofovir DF from non-nucleoside reverse transcriptase inhibitor plus coformulated emtricitabine and tenofovir DF regimens: Week 96 results of STRATEGY-NNRTI
Pozniak, Anton, Flamm, Jason, Antinori, Andrea, Bloch, Mark, Ward, Douglas, Berenguer, Juan, Cote, Pierre, Andreatta, Kristen, Garner, William, Szwarcberg, Javier, Nguyen-Cleary, Thai, McColl, DamianLanguage:
english
Journal:
HIV Clinical Trials
DOI:
10.1080/15284336.2017.1338844
Date:
July, 2017
File:
PDF, 981 KB
english, 2017